Robin Carhartt-Harris founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first such centre in the world. He then became the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at University of California, San Francisco in 2021 and founded the Carhart-Harris Lab in 2023. Robin and his colleagues have completed multimodal human functional neuroimaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for various disorders, including three trials in depression, plus trials in anorexia and fibromyalgia syndrome. He has published in The New England Journal of Medicine (x4), Nature, Nature Medicine, Nature Neuroscience, Cell, Lancet Psychiatry, Science Advances, JAMA Psychiatry, American Journal of Psychiatry, and more. His current research at UCSF focuses on the mechanisms of action of psilocybin and psilocybin-therapy.